2023
DOI: 10.1089/rej.2022.0063
|View full text |Cite
|
Sign up to set email alerts
|

Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 39 publications
0
0
0
Order By: Relevance
“…The efficacy and potential pharmacological mechanisms of KXS against AD were evaluated and proven to involve multiple targets, multi components and multiple pathways ( Luo et al, 2020 ; Yi et al, 2020 ). KXS improved cognitive function via regulating SIRT3-mediated neuronal cell apoptosis ( Su et al, 2023 ), activating the Wnt/beta-catenin signaling pathway in APP/PS1 mice and AD rats ( Shan et al, 2023 ; Xu et al, 2023 ). Network pharmacology analysis validated the multi-component and multi-target therapeutic mechanisms of KXS for treatment of AD, involving inhibiting Tau protein hyperphosphorylation, inflammation, and apoptosis ( Jiao et al, 2022 ; Wang et al, 2023 ).…”
Section: Herbal Medicine and Admentioning
confidence: 99%
“…The efficacy and potential pharmacological mechanisms of KXS against AD were evaluated and proven to involve multiple targets, multi components and multiple pathways ( Luo et al, 2020 ; Yi et al, 2020 ). KXS improved cognitive function via regulating SIRT3-mediated neuronal cell apoptosis ( Su et al, 2023 ), activating the Wnt/beta-catenin signaling pathway in APP/PS1 mice and AD rats ( Shan et al, 2023 ; Xu et al, 2023 ). Network pharmacology analysis validated the multi-component and multi-target therapeutic mechanisms of KXS for treatment of AD, involving inhibiting Tau protein hyperphosphorylation, inflammation, and apoptosis ( Jiao et al, 2022 ; Wang et al, 2023 ).…”
Section: Herbal Medicine and Admentioning
confidence: 99%